gen 5 glp-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Compound 2 potentiates GLP-1 9-36
Description
Lilly announced the topline results from its phase 3b "TOGETHER PsA" trial, showing that the combination use of ixekizumab (Taltz) and tirzepatide (Zepbound) was superior to IXE alone, yielding both significant weight loss and ACR50 disease control in adults with active psoriatic arthritis (PsA).
Modere CURB introduces Eriomin-powered GlycoLemon to naturally curb appetite and boost gut health, setting a new standard in stimulant-free weight loss!
2022 Feb 17;27(4):1351
Leah Joseph at Josephcarerx Clarifies the Key Differences Between GLP-1 and Ozempic to Help You Make Informed Health Decisions.
